宮頸癌篩查風(fēng)險評估量表的可行性研究(完整版)
【正文】 ompared to women with normal cytology in the Netherlands[J]. Br J Cancer，2006，94（1）：171175. [12] Rughooputh S，Kachaliya S，Jetly D，et al. Cervical cancer and human papillomavirus among slum dwellers in india[J].Br J Blomed Sci，2007，64（1）：2831. [13] Saslow D，Solomon D，Lawson HW，et al. American Cancer Society，American Society for Colposcopy and Cervical Pathology，and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J]. J Low Genit Tract Dis，2012，16（3）：175204. [14] Katki HA，Schiffman M，Castle PE，et al. Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines[J]. J Low Genit Tract Dis，2013，17（5 Suppl 1）：S28S35. [15] Mandelblatt JS，Phillips RN. Cervical cancer：How ofenand whyto screen older women[J]. Geriatrics，1996，51（6）：4548. [16] Wang JL，Yang YZ，Dong WW，et al. Application of human pappillovirus in screening for cervical cancer and precancerous lesions[J]. Asian Pac J Cancer Prev，2003， 14（5）：29792982. [17] Arbyn M，Sankaranarayanan R，Muwonge R，et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India[J]. Int J Cancer，2008，123（1）：153160. [18] Munoz N，Bosch FX，de Sanjose S，et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med，2003，348（6）：518527. [19] Wallin KL，Wiklund F，Angstoom T，et al. Typespecific persistence of
試題試卷相關(guān)推薦
鄂ICP備17016276號-1